journal article·2010-08-24Open access

Acetal‐Modified Dextran Microparticles with Controlled Degradation Kinetics and Surface Functionality for Gene Delivery in Phagocytic and Non‐Phagocytic Cells

Joel A. Cohen, Tristan T. Beaudette, Jessica L. Cohen, Kyle E. Broaders, Eric M. Bachelder, Jean M. J. Fréchet

Advanced Materials· Volume 22· Issue 32

Abstract

A microparticulate gene delivery system based on biodegradable and acid-sensitive acetal-modified dextran with unprecedented tunability of degradation rates and simplicity of surface functionalization is presented. When optimally formulated with small amounts of cationic polymers, these microparticles are capable of efficiently transfecting both phagocytic and non-phagocytic cells with minimal toxicity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · Membrane Separation Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. 10.1038/nrg157710.1038/nrg1577 ↗
2. 10.1038/nmat164510.1038/nmat1645 ↗
3. 10.1038/nrd177510.1038/nrd1775 ↗
4. 10.1016/j.addr.2006.03.00710.1016/j.addr.2006.03.007 ↗
5. 10.1007/s11095-006-9180-510.1007/s11095-006-9180-5 ↗
6. 10.1016/j.jconrel.2007.10.02810.1016/j.jconrel.2007.10.028 ↗
7. 10.1016/S0169-409X(02)00228-410.1016/S0169-409X(02)00228-4 ↗
8. 10.1002/adma.20070180310.1002/adma.200701803 ↗
9. 10.1021/bc034159n10.1021/bc034159n ↗
10. 10.1002/jps.1041410.1002/jps.10414 ↗
11. 10.1021/ja803947s10.1021/ja803947s ↗
12. 10.1073/pnas.090159210610.1073/pnas.0901592106 ↗
13. 10.1023/A:100758291195810.1023/A:1007582911958 ↗
14. 10.1007/s11095-008-9594-310.1007/s11095-008-9594-3 ↗
15. 10.1016/j.biomaterials.2007.08.01410.1016/j.biomaterials.2007.08.014 ↗
16. 10.1038/nmat229910.1038/nmat2299 ↗
17. 10.1021/ja001538810.1021/ja0015388 ↗
18. 10.1073/pnas.040354910110.1073/pnas.0403549101 ↗
19. 10.1016/j.jconrel.2005.04.02210.1016/j.jconrel.2005.04.022 ↗
20. 10.1074/jbc.M30864320010.1074/jbc.M308643200 ↗
21. 10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.0.CO;2-F10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.0.CO;2-F ↗
22. 10.1016/j.biomaterials.2008.06.00310.1016/j.biomaterials.2008.06.003 ↗
23. 10.1016/j.addr.2006.09.01710.1016/j.addr.2006.09.017 ↗
24. 10.1021/js980047710.1021/js9800477 ↗
25. 10.1073/pnas.97.24.1300310.1073/pnas.97.24.13003 ↗
26. Beaudette T. T. · J. Am. Chem. Soc. · 2009
27. 10.1016/j.biomaterials.2008.03.01110.1016/j.biomaterials.2008.03.011 ↗
28. 10.1080/0265204070165934710.1080/02652040701659347 ↗
29. 10.1080/1061186029000747810.1080/10611860290007478 ↗
30. Bachelder E. M. · Mol. Pharmaceutics · 2010